Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Abstract

Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.
Original languageEnglish
Pages (from-to)529-536
Number of pages8
JournalAnticancer Research
Volume32
Publication statusPublished - 2012

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma'. Together they form a unique fingerprint.

Cite this